Vertex Pharmaceuticals (VRTX)

Operating Cash Flow Growth

4.87%

Quarterly · Period ending:

VRTX logo

VRTX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported4.87%
VRTX Quarterly Cash from Operations YoY % (-100.00% → 4.87%)
High-resolution chart · PNG

VRTX operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
4.8737%
74.3925%
-14.8135%
-9.3736%
128.5886%
-37.3259%
149.1901%
7.9943%
-430.8886%
45.1939%
-78.2455%
32.7473%
-0.4738%
-5.8879%
8.3827%
3.0501%
670.5647%
3.8157%
102.4269%
2.145%
-119.2356%
12.9162%
10.207%
171.1403%
123.9416%
151.1509%
41.7798%
-12.2091%
44.1544%
28.5474%
38.2694%
124.2089%
77.0975%
-4.9061%
57.2034%
159.0563%
344.5742%
1,855.2487%
1,003.7342%
239.6223%
142.9143%
92.6938%
86.8598%
46.3484%
25.5683%
-17.8759%
-522.3531%
-538.8265%
-13,699.3528%
-167.2048%
-28.8567%
-112.9482%
-100.7829%
-2,355.7613%
-91.9472%
147.0241%
154.7677%
101.5625%
403.2233%
126.1571%
-98.5499%
5.0055%
-62.3257%
-657.9847%
7.7737%
-5.8758%
-5.2476%
83.0287%
-213.7888%
-75.827%
-84.5157%
-100.3111%
251.8373%
-55.638%
-1,129.1113%
-162.6993%
-15.8574%
-11.6953%
38.7834%
280.2525%
-9.4083%
-10.7204%
70.379%
-28.9319%
-134.6872%
-5.7025%
17.6266%
10.0078%
43.0254%
-3.5948%
-112.9786%
-165.4052%
-130.4412%
-65.3578%
-131.8906%
53.1848%
-536.913%
-255.244%
405.7006%
-281.1104%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.